BIOCIUS Life Sciences develops and markets innovative technologies for drug discovery, with applications for high-throughput screening and in vitro absorption, distribution, metabolism, excretion, and toxicology (ADME-Tox) assays. BIOCIUS' RapidFire mass spec front-end employs nano-scale fluidics to increase throughput from as much as 10x over other sample preparation technologies, accelerating customers' research, development and commercialization projects.